Skip to main content

Table 3 Myocardial injury assessed by MRI

From: Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trial

 

Morphine group

(n = 38)

Placebo group

(n = 35)

P value

LV mass, g

131 ± 34

128 ± 33

0.63

Infarct size, g

36.6 ± 22.5

39.5 ± 17.7

0.54

Infarct size/LV mass, %

27.2 ± 15.0

30.5 ± 10.6

0.28

Area at risk/LV mass, %

31.3 ± 12.5

36.0 ± 11.2

0.15

Infarct size/Area at risk, %

80.5 ± 19.4

84.1 ± 19.5

0.49

LV ejection fraction, %

49.2 ± 11.0

47.6 ± 8.7

0.50

LV end-diastolic volume, mL/m2

82.2 ± 16.8

78.4 ± 21.6

0.41

LV end-systolic volume, mL/m2

42.5 ± 14.9

41.7 ± 15.7

0.83

  1. LV left ventricle
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us